AnaptysBio, Inc. (NASDAQ:ANAB) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| James N Topper Other companies: Attovia Therapeutics, Inc. (Director · Since at least Aug 4, 2026); NewAmsterdam Pharma Company N.V. (Director · Since at least Dec 29, 2023); Phathom Pharmaceuticals, Inc. (Director · Since at least Oct 24, 2019); Frazier Lifesciences Acquisition Corp (Chief Executive Officer, Director · Dec 8, 2020 – Dec 11, 2020 · Past); Entasis Therapeutics Holdings Inc (Director · Sep 25, 2018 – Jan 18, 2019 · Past); Aptinyx Inc (Director · Jun 20, 2018 – Mar 31, 2020 · Past); Allena Pharmaceuticals Inc (Director · Nov 1, 2017 – Nov 17, 2020 · Past); Alpine Immune Sciences Inc (Director · Jul 24, 2017 – May 18, 2024 · Past); Sierra Oncology Inc (Director · Jul 15, 2015 – Feb 14, 2017 · Past); Portola Pharmaceuticals Inc (Director · May 21, 2013 – Jun 5, 2013 · Past); Amicus Therapeutics Inc (Director · Jun 15, 2010 – Jun 12, 2014 · Past) | Director · Jan 25, 2017 – Jan 6, 2023 · Past |
| John Schmid Other companies: BlossomHill Therapeutics, Inc. (Director · Since at least Aug 6, 2026); First Tracks Biotherapeutics, Inc. (Director · Since at least Apr 1, 2026); Helix Acquisition Corp. III (Director · Since at least Jan 22, 2026); Design Therapeutics, Inc. (Director · Since at least Mar 25, 2021); BridgeBio Oncology Therapeutics, Inc. (Director · Feb 8, 2024 – Feb 8, 2024 · Past); Xeris Biopharma Holdings, Inc. (Director · Oct 5, 2021 – Aug 12, 2024 · Past); MoonLake Immunotherapeutics (Director · Oct 19, 2020 – Oct 19, 2020 · Past); Poseida Therapeutics Inc (Director · Jul 9, 2020 – Jan 8, 2025 · Past); Neos Therapeutics Inc (Director · Jul 2, 2018 – Mar 19, 2021 · Past) | Director · Since at least Feb 2, 2018 |
| John Orwin Other companies: First Tracks Biotherapeutics, Inc. (Director · Since at least Apr 1, 2026); CARGO Therapeutics, Inc. (Director · Since at least Nov 9, 2023); Travere Therapeutics, Inc. (Director · Since at least Mar 23, 2017); Atreca Inc (PRESIDENT & CEO, Director · Jun 19, 2019 – Apr 11, 2024 · Past); Seagen Inc (Director · Jan 10, 2014 – Dec 14, 2023 · Past); Relypsa Inc (President & CEO, Director · Nov 14, 2013 – Sep 1, 2016 · Past); Affymax Inc (Director · Apr 12, 2010 – Jun 27, 2013 · Past); NeurogesX Inc (Director · Nov 19, 2009 – Jun 7, 2012 · Past) | Board Chairman of First Tracks Bio Former CEO of Relypsa · Since at least Sep 15, 2023 |
| Hollings Renton Other companies: Zymeworks Inc. (Director · Jan 1, 2019 – Dec 7, 2023 · Past); Kythera Biopharmaceuticals Inc (Director · Dec 31, 2014 – Oct 1, 2015 · Past); Portola Pharmaceuticals Inc (Director · May 21, 2013 – Jul 2, 2020 · Past); Affymax Inc (Director · Jun 9, 2009 – Jun 13, 2012 · Past); Rigel Pharmaceuticals, Inc. (Director · May 31, 2006 – May 15, 2013 · Past); Cepheid (Director · Apr 27, 2006 – Nov 4, 2016 · Past); Onyx Pharmaceuticals Inc (President and CEO, Director · Jan 19, 2006 – Feb 19, 2008 · Past) | Chair of the Nominating and Corporate Governance Committee · Since at least Jan 25, 2017 |
| Oleg Nodelman Other companies: Theravance Biopharma, Inc. (BSFS · Since at least Nov 5, 2026); Aktis Oncology, Inc. (Director · Since at least Jan 8, 2026); Zymeworks Inc. (Director · Since at least Feb 17, 2025); Nuvation Bio Inc. (Director · Jun 30, 2020 – Sep 19, 2023 · Past); Panacea Acquisition II Corp (Director · Apr 6, 2020 – Apr 28, 2023 · Past); Prothena Corporation plc (Director · Dec 3, 2019 – Dec 3, 2019 · Past); Kindred Biosciences Inc (Director · Dec 11, 2013 – Sep 29, 2014 · Past) | Member of the Nominating and Corporate Governance Committee · Since at least Apr 8, 2021 |
| Owen Hughes Other companies: XOMA Royalty Corporation (Chief Executive Officer, Director · Since at least Nov 11, 2024); C4 Therapeutics, Inc. (Director · Since at least Nov 16, 2023); ImageneBio, Inc. (Director · Dec 14, 2022 – Jun 7, 2024 · Past); Pardes Biosciences Inc (Director · Feb 16, 2021 – Dec 23, 2021 · Past); Cullinan Therapeutics, Inc. (President and CEO, Director · Jan 7, 2021 – Jan 12, 2021 · Past); Translate Bio Inc (Director · Jun 27, 2018 – Sep 14, 2021 · Past); Radius Health, Inc. (Director · Apr 23, 2013 – Aug 15, 2022 · Past) | Member of the Audit Committee · Since at least May 11, 2026 |
| Dennis M Fenton Other companies: First Tracks Biotherapeutics, Inc. (Director · Since at least Apr 1, 2026); Portola Pharmaceuticals Inc (Director · Jun 17, 2016 – Jul 2, 2020 · Past); XenoPort Inc (Director · May 17, 2016 – Jul 5, 2016 · Past); Pfenex Inc (Director · May 6, 2016 – May 5, 2017 · Past) | Director · Since at least Mar 5, 2018 |
| Rita Jain Other companies: First Tracks Biotherapeutics, Inc. (Director · Since at least Apr 1, 2026); SAB Biotherapeutics, Inc. (Director · Since at least Jan 5, 2026); Avalo Therapeutics, Inc. (Director · Since at least Jun 17, 2025); Celldex Therapeutics, Inc. (Director · Since at least Jun 13, 2024) | Director · Since at least Jan 3, 2024 |
| Susannah Gray Other companies: Maravai LifeSciences Holdings, Inc. (Director · Since at least May 23, 2024); 4D Molecular Therapeutics, Inc. (Director · Since at least May 21, 2024); Theravance Biopharma, Inc. (Director · Since at least May 8, 2024); Morphic Holding Inc (Director · Jun 4, 2024 – Aug 16, 2024 · Past) | Director · Since at least Mar 26, 2026 |
| Dan Faga Other companies: First Tracks Biotherapeutics, Inc. (President, CEO, Director · Since at least Apr 1, 2026); Spark Therapeutics Inc (Chief Business Officer · May 2, 2016 – Dec 17, 2019 · Past) | President, CEO, and Director · Since at least Nov 26, 2021 |
| Dennis Mulroy Other companies: Arcturus Therapeutics Holdings Inc. (Chief Financial Officer · Since at least May 1, 2026); La Jolla Pharmaceutical Co (Chief Financial Officer · Apr 6, 2015 – May 29, 2020 · Past) | CHIEF FINANCIAL OFFICER · Since at least Jul 13, 2020 |
| J Anthony Ware Other companies: First Tracks Biotherapeutics, Inc. (Director · Since at least Apr 1, 2026) | Director · Since at least Aug 22, 2017 |
| Nick Montemarano Other companies: First Tracks Biotherapeutics, Inc. (Vice President, Investor Relations · Since at least Nov 3, 2026) | Executive Director, Investor Relations · Since at least Mar 3, 2026 |
| Christopher Murphy | CFO · Since at least May 11, 2026 |
| Eric J Loumeau | CHIEF LEGAL OFFICER · Since at least Sep 30, 2025 |
| Hamza Suria | President, CEO, Director · Jan 25, 2017 – Feb 10, 2022 · Past |
| Marco Londei | Chief Medical Officer · Jan 25, 2017 – Dec 6, 2019 · Past |
| Matthew Moyle | Chief Scientific Officer · Jan 25, 2017 – Feb 24, 2017 · Past |